Dihydropyridine calcium channel blockers may be linked to worse kidney outcomes for patients with type 2 diabetes, according to study data presented at the European Renal Association Congress in ...

For adults with type 2 diabetes receiving guideline-directed renin-angiotensin inhibitors (RASi) and sodium-glucose cotransporter-2 inhibitors (SGLT2i), dihydropyridine calcium-channel-blocker (DCCB) ...

For adults with type 2 diabetes receiving guideline-directed renin-angiotensin inhibitors (RASi) and sodium-glucose ...

Dihydropyridine calcium-channel-blockers (DCCBs), used to treat high blood pressure, could speed up the progression of kidney ...

Key Takeaways Common blood pressure meds might increase risk of kidney damage among people with type 2 ...

New research presented at the 63rd ERA Congress suggests that a widely used class of blood pressure medications may be ...

New research presented at the 63rd ERA Congress suggests that a widely used class of blood pressure medications may be ...

(Glasgow, Scotland) New research presented at the 63 rd ERA Congress suggests that a widely used class of blood pressure medications may be associated with poorer kidney outcomes in people with type 2 ...

She met her future husband in college in Alpine, Texas, and they were married for nearly two decades before his death in 1972. By Mike Barnes Senior Editor Dolphia Blocker, the wife of late Bonanza ...

Background: Beta-blockers (BB) and non-dihydropyridine calcium channel blockers (CCB) are first-line therapies for hypertrophic cardiomyopathy (HCM) used both upon symptom onset and for ...

Calcium channel blocker (CCB) overdose presents as profound hypotension, bradycardia and, in severe cases, cardiogenic shock. The principal mechanism involves impaired calcium influx into cardiac and ...

Researchers at Baylor College of Medicine have uncovered a previously unrecognized mechanism by which inherited calcium channel mutations disrupt early brain development and predispose children to ...